| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 111,630 | 100,972 | 19,046 | | Cost of Revenue | 32,876 | 34,532 | 7,048 | | | Gross Profit | 78,755 | 66,440 | 11,998 | | | Operating Expenses | | Research Development | 3,235 | 4,108 | 1,138 | | Selling General and Administrative | 53,205 | 46,520 | 8,731 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 22,314 | 15,812 | 2,130 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 287 | 653 | 203 | | Earnings Before Interest And Taxes | 22,602 | 16,465 | 2,333 | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | 22,602 | 16,465 | 2,333 | | Income Tax Expense | 8,737 | 6,037 | 624 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 13,864 | 10,428 | 1,709 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 13,864 | 10,428 | 1,709 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $13,864 | $10,428 | $1,709 |
|
1.48% Nasdaq 
Income Statement
